Detailed information for compound 420750

Basic information

Technical information
  • TDR Targets ID: 420750
  • Name: 5,6-dichloro-1-methyl-2-methylsulfanylbenzimi dazole
  • MW: 247.144 | Formula: C9H8Cl2N2S
  • H donors: 0 H acceptors: 1 LogP: 3.54 Rotable bonds: 1
    Rule of 5 violations (Lipinski): 1
  • SMILES: CSc1nc2c(n1C)cc(c(c2)Cl)Cl
  • InChi: 1S/C9H8Cl2N2S/c1-13-8-4-6(11)5(10)3-7(8)12-9(13)14-2/h3-4H,1-2H3
  • InChiKey: AVTMPBGZZKTKJC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 5,6-dichloro-1-methyl-2-methylsulfanyl-benzimidazole
  • 5,6-dichloro-1-methyl-2-(methylthio)benzimidazole

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans hydrolase 0.0048 0.0099 0.5
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Treponema pallidum ribonuclease Z 0.0048 0.0099 0.5
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Giardia lamblia Prenyltransferase 0.0111 0.1044 1
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Plasmodium falciparum protein farnesyltransferase subunit beta 0.0111 0.1044 1
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0142 0.1516 0.1431
Loa Loa (eye worm) acetyltransferase 0.0142 0.1516 0.1431
Trichomonas vaginalis geranylgeranyl transferase type I beta subunit, putative 0.0111 0.1044 1
Mycobacterium leprae Beta-lactamase-like protein 0.0048 0.0099 0.5
Trypanosoma cruzi protein farnesyltransferase, putative 0.0111 0.1044 0.853
Trichomonas vaginalis disulfide oxidoreductase, putative 0.0048 0.0099 0.0949
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Echinococcus granulosus hydroxyacylglutathione hydrolase 0.0048 0.0099 0.0099
Mycobacterium ulcerans hypothetical protein 0.0048 0.0099 0.5
Plasmodium vivax conserved Plasmodium protein, unknown function 0.0081 0.0589 0.5647
Plasmodium vivax hydroxyacyl glutathione hydrolase, putative 0.0048 0.0099 0.0949
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0142 0.1516 0.1431
Loa Loa (eye worm) hypothetical protein 0.0373 0.5015 0.4965
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Toxoplasma gondii prenyltransferase and squalene oxidase repeat-containing protein 0.0111 0.1044 1
Echinococcus granulosus metallo beta lactamase domain containing protein 0.0048 0.0099 0.0099
Toxoplasma gondii hydroxyacylglutathione hydrolase 0.0048 0.0099 0.0949
Mycobacterium ulcerans hypothetical protein 0.0048 0.0099 0.5
Plasmodium vivax farnesyltransferase beta subunit, putative 0.0111 0.1044 1
Mycobacterium ulcerans hypothetical protein 0.0048 0.0099 0.5
Entamoeba histolytica protein farnesyltransferase beta subunit, putative 0.0111 0.1044 1
Loa Loa (eye worm) prenyltransferase and squalene oxidase repeat family protein 0.0111 0.1044 0.0954
Trichomonas vaginalis A-type flavoprotein 0.0048 0.0099 0.0949
Mycobacterium ulcerans hypothetical protein 0.0048 0.0099 0.5
Loa Loa (eye worm) hypothetical protein 0.0703 1 1
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.0111 0.1044 1
Mycobacterium ulcerans glyoxalase II, GloB 0.0048 0.0099 0.5
Toxoplasma gondii metallo-beta-lactamase domain-containing protein 0.0048 0.0099 0.0949
Trichomonas vaginalis type I geranylgeranyltransferase beta subunit, putative 0.0111 0.1044 1
Brugia malayi acetyltransferase, GNAT family protein 0.0142 0.1516 0.1431
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Trypanosoma cruzi lanosterol synthase, putative 0.0122 0.1207 1
Plasmodium vivax unspecified product 0.0048 0.0099 0.0949
Trypanosoma cruzi lanosterol synthase, putative 0.0122 0.1207 1
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Brugia malayi Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein 0.0184 0.215 0.2071
Schistosoma mansoni protein farnesyltransferase subunit beta 0.0111 0.1044 0.0954
Trichomonas vaginalis apoptosis inducing factor, putative 0.0048 0.0099 0.0949
Onchocerca volvulus Hydroxyacylglutathione hydrolase, mitochondrial homolog 0.0048 0.0099 0.5
Echinococcus granulosus metallo beta lactamase domain containing protein 0.0048 0.0099 0.0099
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.0111 0.1044 1
Leishmania major lanosterol synthase, putative 0.0092 0.0752 0.6913
Mycobacterium leprae conserved hypothetical protein 0.0048 0.0099 0.5
Mycobacterium ulcerans hydrolase 0.0048 0.0099 0.5
Onchocerca volvulus Putative hydrolase PNKD 0.0048 0.0099 0.5
Brugia malayi Prenyltransferase and squalene oxidase repeat family protein 0.0111 0.1044 0.0954
Trichomonas vaginalis beta lactamase domain, putative 0.0048 0.0099 0.0949
Mycobacterium ulcerans Zn-dependent glyoxylase 0.0048 0.0099 0.5
Mycobacterium ulcerans beta lactamase-like protein 0.0048 0.0099 0.5
Trypanosoma brucei lanosterol synthase 0.0122 0.1207 1
Echinococcus granulosus protein farnesyltransferase subunit beta 0.0111 0.1044 0.1044
Schistosoma mansoni peptidylglycine monooxygenase 0.0373 0.5015 0.4965
Mycobacterium tuberculosis Halimadienyl diphosphate synthase 0.0122 0.1207 1
Leishmania major farnesyltransferase beta subunit 0.0111 0.1044 1
Onchocerca volvulus 0.0048 0.0099 0.5
Brugia malayi Copper type II ascorbate-dependent monooxygenase, N-terminal domain containing protein 0.019 0.2234 0.2156
Echinococcus granulosus histone acetyltransferase KAT2B 0.0138 0.1455 0.1455
Mycobacterium leprae conserved hypothetical protein 0.0048 0.0099 0.5
Brugia malayi Copper type II ascorbate-dependent monooxygenase, C-terminal domain containing protein 0.0373 0.5015 0.4965
Mycobacterium ulcerans hydrolase 0.0048 0.0099 0.5
Schistosoma mansoni peptidyl-glycine monooxygenase 0.0703 1 1
Echinococcus granulosus peptidyl glycine alpha amidating monooxygenase 0.0703 1 1
Echinococcus granulosus zinc phosphodiesterase 0.0048 0.0099 0.0099
Echinococcus multilocularis peptidyl glycine alpha amidating monooxygenase 0.0703 1 1
Trichomonas vaginalis geranylgeranyl transferase type beta subunit, putative 0.0111 0.1044 1
Trichomonas vaginalis geranylgeranyl transferase type II beta subunit, putative 0.0111 0.1044 1
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Chlamydia trachomatis ribonuclease Z 0.0048 0.0099 0.5
Onchocerca volvulus 0.0048 0.0099 0.5
Mycobacterium leprae POSSIBLE HYDROLASE 0.0048 0.0099 0.5
Trypanosoma cruzi protein farnesyltransferase, putative 0.0111 0.1044 0.853
Wolbachia endosymbiont of Brugia malayi metallo-beta-lactamase superfamily hydrolase 0.0048 0.0099 0.5
Echinococcus multilocularis protein farnesyltransferase subunit beta 0.0111 0.1044 0.0954
Echinococcus granulosus ETHE1 protein 0.0048 0.0099 0.0099
Schistosoma mansoni dopamine-beta-monooxygenase 0.0373 0.5015 0.4965
Trichomonas vaginalis conserved hypothetical protein 0.0048 0.0099 0.0949
Trypanosoma brucei protein farnesyltransferase beta subunit 0.0111 0.1044 0.853

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = -5.98 Antiamoebic activity against Entamoeba histolytica ChEMBL. 17074492
Log IC50 (functional) = 5.98 Antiamoebic activity against Entamoeba histolytica ChEMBL. 17074492

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Entamoeba histolytica ChEMBL23 17074492

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.